Beroni Group Past Earnings Performance
Past criteria checks 0/6
Beroni Group's earnings have been declining at an average annual rate of -21%, while the Biotechs industry saw earnings growing at 14.7% annually. Revenues have been declining at an average rate of 8.2% per year.
Key information
-21.0%
Earnings growth rate
-17.9%
EPS growth rate
| Biotechs Industry Growth | 9.6% |
| Revenue growth rate | -8.2% |
| Return on equity | -50.7% |
| Net Margin | -233.5% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Beroni Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 2 | -4 | 6 | 0 |
| 31 Mar 22 | 2 | -4 | 6 | 0 |
| 31 Dec 21 | 2 | -3 | 5 | 0 |
| 30 Jun 21 | 2 | -3 | 4 | 0 |
| 31 Mar 21 | 2 | -4 | 5 | 0 |
| 31 Dec 20 | 2 | -5 | 6 | 0 |
| 30 Jun 20 | 1 | -8 | 9 | 0 |
| 31 Mar 20 | 2 | -8 | 9 | 0 |
| 31 Dec 19 | 2 | -8 | 9 | 0 |
| 30 Sep 19 | 2 | -6 | 8 | 0 |
| 30 Jun 19 | 2 | -5 | 6 | 0 |
| 31 Mar 19 | 2 | -3 | 5 | 0 |
| 31 Dec 18 | 2 | -2 | 5 | 0 |
| 30 Sep 18 | 2 | -2 | 5 | 0 |
| 30 Jun 18 | 2 | -2 | 5 | 0 |
| 31 Mar 18 | 2 | -2 | 4 | 0 |
| 31 Dec 17 | 2 | -1 | 3 | 0 |
| 30 Sep 17 | 3 | 0 | 3 | 0 |
| 30 Jun 17 | 3 | 0 | 3 | 0 |
| 31 Mar 17 | 4 | 0 | 2 | 0 |
| 31 Dec 16 | 4 | 0 | 2 | 0 |
| 31 Dec 15 | 1 | 0 | 1 | 0 |
Quality Earnings: BTG is currently unprofitable.
Growing Profit Margin: BTG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BTG is unprofitable, and losses have increased over the past 5 years at a rate of 21% per year.
Accelerating Growth: Unable to compare BTG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BTG is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-9.8%).
Return on Equity
High ROE: BTG has a negative Return on Equity (-50.72%), as it is currently unprofitable.